Literature DB >> 6785848

The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.

J L Au, W Sadée.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6785848     DOI： 10.1007/978-3-642-81565-2_9

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  4 in total

1.  Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation.

Authors:  F A Calvo; A Aldaz; L Zufía; D de la Mata; J Serrano; R García; J A Arranz; A Alvarado; J Giráldez
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

2.  White light-mediated Cu (II)-5FU interaction augments the chemotherapeutic potential of 5-FU: an in vitro study.

Authors:  Sandesh Chibber; Mohd Farhan; Iftekhar Hassan; Imrana Naseem
Journal:  Tumour Biol       Date:  2011-05-27

Review 3.  Cytochrome P450-activated prodrugs.

Authors:  Paul R Ortiz de Montellano
Journal:  Future Med Chem       Date:  2013-02       Impact factor: 3.808

Review 4.  Radiation- and photo-induced activation of 5-fluorouracil prodrugs as a strategy for the selective treatment of solid tumors.

Authors:  Takeo Ito; Kazuhito Tanabe; Hisatsugu Yamada; Hiroshi Hatta; Sei-ichi Nishimoto
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.